Anzeige
Meldung des Tages: Warum Kupfer und Silber aus Nevada plötzlich wieder im Fokus stehen könnten

PAVmed Aktie News

Aktie
WKN:  ISIN:  US70387R5028 US-Symbol:  PAVM
8,05 $
-0,60 $
-6,94%
6,7486 € 19:15:29 Uhr
Depot/Watchlist
Marktkapitalisierung *
-
Streubesitz
-
KGV
-
Index-Zuordnung
-

PAVmed News

13.08.25 - PR Newswire
Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results
Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results PR Newswire
05.08.25 - PR Newswire
Lucid Diagnostics to Participate in Upcoming Investor Conferences
Lucid Diagnostics to Participate in Upcoming Investor Conferences PR Newswire
31.07.25 - PR Newswire
PAVmed to Hold a Business Update Conference Call and Webcast on August 14, 2025
PAVmed to Hold a Business Update Conference Call and Webcast on August 14, 2025 PR Newswire
30.07.25 - PR Newswire
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025 PR Newswire
16.07.25 - PR Newswire
MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA Test
MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA Test PR Newswire
24.06.25 - PR Newswire
PAVmed Subsidiary Veris Health Completes $2.5 Million Direct Equity Financing
PAVmed Subsidiary Veris Health Completes $2.5 Million Direct Equity Financing PR Newswire
18.06.25 - PR Newswire
Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test
Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test PR Newswire
03.06.25 - PR Newswire
PAVmed Subsidiary, Veris Health, Enters into Strategic Partnership Agreement with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
PAVmed Subsidiary, Veris Health, Enters into Strategic Partnership Agreement with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove ...
27.05.25 - PR Newswire
Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes
Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes PR Newswire
15.05.25 - PR Newswire
PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results
PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results PR Newswire
14.05.25 - PR Newswire
Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results
Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results PR Newswire
01.05.25 - PR Newswire
PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025
PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025 PR Newswire
30.04.25 - PR Newswire
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 PR Newswire
24.04.25 - PR Newswire
NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD
NCI-​Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD PR Newswire
11.04.25 - PR Newswire
Lucid Diagnostics Announces Closing of Public Offering of Common Stock
Lucid Diagnostics Announces Closing of Public Offering of Common Stock PR Newswire
09.04.25 - PR Newswire
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock PR Newswire
09.04.25 - PR Newswire
Lucid Diagnostics Announces Proposed Public Offering of Common Stock
Lucid Diagnostics Announces Proposed Public Offering of Common Stock PR Newswire
03.04.25 - PR Newswire
Lucid Diagnostics to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference
Lucid Diagnostics to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference PR Newswire
27.03.25 - PR Newswire
Lucid Diagnostics Launches "Embrace the Future" Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal Cell Collection Technology
Lucid Diagnostics Launches "Embrace the Future" Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal Cell Collection Technology PR Newswire
24.03.25 - PR Newswire
Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results PR Newswire

Newssuche

Videos

newspaper
27.01.26 +0,22%
Technical Trading: Pfund Short
GBP/USD Short Typ: Turbo Open End WKN: VH3A2E Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »